Company / Total Debt
Arcutis Biotherapeutics, Inc. Total Debt History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$109.0M
FY2025
5-year range
$72.3M / $201.8M
FY2021-FY2025
Trend
+1.6%
vs FY2024
Sector context
#56 of 83
Health Care
What the data says
At $109M, Arcutis Biotherapeutics, Inc.'s total debt ranks #28 of 83 in the Health Care sector. Improved from $202M to $109M over the past 2 years.
Based on SEC 10-K filings.
$109M in FY2025 with a 3-year CAGR of -18.0%.
Improved from $202M to $109M over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- -18.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#28 of 83 in Health CareTop 33% of 83This company $109.0M Sector average $6.2B
▼
-98.2% below sector average
Key checks
Key Insights
- 3-year CAGR of -18.0%, indicating a declining trend.
- In FY2025, total debt increased 1.6% year-over-year.
- Ranks #56 out of 83 companies in the Health Care sector.
- Peak total debt was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $109.0M | +1.6% |
| FY2024 | $107.2M | -46.9% |
| FY2023 | $201.8M | +2.0% |
| FY2022 | $197.8M | +173.4% |
| FY2021 | $72.3M | - |
| FY2020 | $0 | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026